KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to $483.8 million.

  • Zimmer Biomet Holdings' Cash from Financing Activities rose 57477.92% to $483.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $982.4 million, marking a year-over-year increase of 29834.44%. This contributed to the annual value of -$484.5 million for FY2024, which is 3654.22% up from last year.
  • As of Q3 2025, Zimmer Biomet Holdings' Cash from Financing Activities stood at $483.8 million, which was up 57477.92% from $163.8 million recorded in Q2 2025.
  • Zimmer Biomet Holdings' Cash from Financing Activities' 5-year high stood at $575.4 million during Q1 2025, with a 5-year trough of -$655.8 million in Q4 2021.
  • Moreover, its 5-year median value for Cash from Financing Activities was -$146.0 million (2022), whereas its average is -$110.9 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first tumbled by 90023.47% in 2021, then soared by 124850.3% in 2025.
  • Zimmer Biomet Holdings' Cash from Financing Activities (Quarter) stood at -$655.8 million in 2021, then soared by 52.21% to -$313.4 million in 2022, then grew by 19.78% to -$251.4 million in 2023, then increased by 4.3% to -$240.6 million in 2024, then surged by 301.08% to $483.8 million in 2025.
  • Its Cash from Financing Activities stands at $483.8 million for Q3 2025, versus $163.8 million for Q2 2025 and $575.4 million for Q1 2025.